Home/Filings/4/0001437749-25-008738
4//SEC Filing

Bode John B 4

Accession 0001437749-25-008738

CIK 0001434647other

Filed

Mar 20, 8:00 PM ET

Accepted

Mar 21, 4:06 PM ET

Size

5.0 KB

Accession

0001437749-25-008738

Insider Transaction Report

Form 4
Period: 2025-03-19
Bode John B
Director
Transactions
  • Purchase

    Common Stock

    2025-03-19$7.96/sh+10,000$79,62440,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.91 to $8.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Issuer

ZEVRA THERAPEUTICS, INC.

CIK 0001434647

Entity typeother

Related Parties

1
  • filerCIK 0001612084

Filing Metadata

Form type
4
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 4:06 PM ET
Size
5.0 KB